Published on
September 11, 2025
- 14:51 GMT
DNA Nanobots Receives SBIR Grant to Advance Revolutionary Non-Viral Gene Therapy Platform
Backed by NIH, DNA Nanobots aims to disrupt gene therapy with scalable, non-viral platform—$5M round now open to select investors. POWELL, OH, UNITED STATES, September 11, 2025 /EINPresswire.com/ -- DNA Nanobots, Inc., a pioneering biotechnology company …
Distribution channels:
Business & Economy, Companies
...
